Michael Scolaro

Michael Scolaro

Nov 29, 2017

Group 6 Copy 258
-3
References
  • 1. https://www.ncbi.nlm.nih.gov/pubmed/26558876
  • 2. https://www.ncbi.nlm.nih.gov/pubmed/26558876
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Unlock the Secrets of Animals that Survive Freezing!

The North American wood frog Rana sylvatica can survive being frozen solid - no heartbeat, no brain activity...

How does Sprint Training Impact Blood Sugar and Inflammation?

Exercise intensity has a huge effect on how endurance training, like running, effects health. While research...

Finding a Cure for Batten Disease

In March of this year, both of our daughters, Charlotte and Gwenyth, were diagnosed with Late Infantile...

Backer Badge Funded